Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.51
UNSPSC Code:
41105324
description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
TTTGGCCTGAGTGTGTTCAGGCCCAGCGTTTTTCCCAGGCAGATAACATTGCACAGCTTCAAAAAAACATTGTGACCCTTGCCAGAAATGTGGCCTTTGAAGAGGTTGCTGAGGCTGCTGTGGACCAGTTGCTGCAGTCCCATGAAGAAGATCTCTCAAATGAGGAACTGATGCGGCTGGAACAGGAGCTGGCAGTGGGGGAGGAGGAGAGGGAAGATGGTCC
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
human ... CENPBD1(92806), MC1R(4157)
General description
MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
Storage Class
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Wen-Tsan Weng et al.
International journal of molecular sciences, 19(12) (2018-12-06)
α-melanocyte-stimulating hormone (α-MSH) has been characterized as a novel angiogenesis inhibitor. The homeostasis of nitric oxide (NO) plays an important role in neovascularization. However, it remains unclear whether α-MSH mitigates angiogenesis through modulation of NO and its signaling pathway. The
Global Trade Item Number
| SKU | GTIN |
|---|---|
| EHU126551-20UG | 04061831359794 |
| EHU126551-50UG | 04061828358595 |